Nanomedicine_FCT/UNL

15/02/2019

Happy Valentine's day

22/11/2017

Anti-angiogenic therapy has great potential for cancer therapy with several FDA approved formulations but there are considerable side effects upon the normal blood vessels that decrease the potential application of such therapeutics. Chicken chorioallantoic membrane (CAM) has been used as a model to...

07/09/2017

Photothermal Therapy (PTT) impact in cancer therapy has been increasing due to the enhanced photothermal capabilities of a new generation of nanoscale photothermal agents. Among these nanoscale agents, gold nanoshells and nanorods have demonstrated optimal properties for translation of near infra-re...

02/08/2017

21/04/2017

Woldwide solutions for molecular testing at point of care
IMPROVING LIVES OF MILLIONS

NANO4 Global aims to provide solutions for one step molecular identification of DNA/RNA at point-of-care (PoC). NANO4 Global spins around an awarded platform — NANO4 - the next generation of molecular nanodiagnostics applied to lifesciences.

06/12/2016

(2016). Current trends in molecular diagnostics of chronic myeloid leukemia. Leukemia & Lymphoma. Ahead of Print.

22/11/2016

The remarkable physicochemical properties of gold nanoparticles (AuNPs) have prompted developments in the exploration of biomolecular interactions with AuNP-containing systems, in particular for biomedical applications in diagnostics. These systems show great promise in improving sensitivity, ease o...

28/09/2016

"Fazer os diagnósticos clínicos moleculares de doenças como a tuberculose, zika ou cancro de uma forma rápida, fiável e a baixo custo. Esta é a inovação que a startup portuguesa Nano4 se prepara para lançar em breve no mercado mundial e que poderá mudar de forma radical a maneira tradicional de fazer diagnósticos em laboratório."

A Nano4. um startup portuguesa sediada em Lisboa, quer liderar a nível mundial a nova geração de diagnósticos para doenças infecciosas e cancro

24/05/2016

(2016). Precision nanomedicine in cancer: how far are we from personalization? Expert Review of Precision Medicine and Drug Development: Vol. 1, No. 3, pp. 227-228. doi: 10.1080/23808993.2016.1174063

24/05/2016

(2016). Non-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnology. Expert Review of Precision Medicine and Drug Development: Vol. 1, No. 2, pp. 155-168. doi: 10.1080/23808993.2016.1159914